Mathieu Bourdenx

7.7k citations
51 papers · 6k · 7 hit papers · h-index 26

Impact in

  • Neurology top 0.5%
    • Parkinson's Disease Mechanisms and Treatments
    • Neuroinflammation and Neurodegeneration Mechanisms
  • Aging top 2%
    • Genetics, Aging, and Longevity in Model Organisms

Papers in

    • Parkinson's Disease Mechanisms and Treatments 23
    • Neurological disorders and treatments 2
    • Alzheimer's disease research and treatments 10
    • Lysosomal Storage Disorders Research 3

Mathieu Bourdenx

51 papers receiving 5.9k citations

Mathieu Bourdenx's Hit Papers

The different autophagy degradation pathways and neurodegeneration 2022 · 364 citations
3640+3+7Years since publication5001k1.5k2k

Peers

Mathieu Bourdenx
Comparison fields: 5 of 131
  • Neurology 1.5k
  • Aging 107
  • Epidemiology 1.9k
  • Physiology 774
  • Neurology 200
Replace Kuen‐Jer Tsai with:
Kuen‐Jer Tsai Taiwan
Kerri J. Kinghorn United Kingdom
Alicia M. Pickrell United States
Philip Wing‐Lok Ho Hong Kong
Sung Bae Lee South Korea
Matthew E. Gegg United Kingdom
Concepció Marı́n Spain
Sami J. Barmada United States
Olga Corti France
Mathieu Bourdenx relative to Kuen‐Jer Tsai Taiwan Kuen‐Jer Tsai's profile →
Citations per field
00.5×2×2.7×
Kuen‐Jer Tsai · 1×
Citations per year

Countries citing papers authored by Mathieu Bourdenx

Since Specialization
Citations

This map shows the geographic impact of Mathieu Bourdenx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bourdenx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bourdenx more than expected).

Fields of papers citing papers by Mathieu Bourdenx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Bourdenx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bourdenx. The network helps show where Mathieu Bourdenx may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathieu Bourdenx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathieu Bourdenx Line = papers co-authored together Mathieu Bourdenx links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Hit paper breakdown →
20212067
2
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Hit paper breakdown →
2015443
3
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Hit paper breakdown →
2015398
4
The different autophagy degradation pathways and neurodegeneration
Hit paper breakdown →
2022364
5
Selective autophagy as a potential therapeutic target for neurodegenerative disorders
Hit paper breakdown →
2018298
6
Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome
Hit paper breakdown →
2021281
7 2019202
8
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
Hit paper breakdown →
2021186
9 2016183
10 2020167
11 2015159
12 2017123
13 2015103
14 2017100
15 202285
16 201472
17 201471
18 201470
19 202165
20 201961

About Mathieu Bourdenx

Mathieu Bourdenx is a scholar working on Neurology, Physiology, Epidemiology, Biomaterials and Genetics, having authored 51 papers that have together received 6k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (23 papers), Autophagy in Disease and Therapy (13 papers), Alzheimer's disease research and treatments (10 papers), Lysosomal Storage Disorders Research (3 papers), Virus-based gene therapy research (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Neurological disorders and treatments (2 papers) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Neurology (1.5k citations), Aging (107 citations), Epidemiology (1.9k citations), Physiology (774 citations) and Neurology (200 citations). Mathieu Bourdenx has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Benjamin Dehay, Erwan Bézard, Ana María Cuervo, Aurora Scrivo, Olatz Pampliega, Wassilios G. Meissner, Federico Nicolás Soria, Miquel Vila, Kalpana Merchant and Gregory A. Petsko. Their work appears in journals such as Movement Disorders, Science Advances, Nature Cell Biology, Neurobiology of Disease and Journal of Alzheimer s Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact